Ulcerative colitis: focus on topical treatment

Available
Delivered in France : 0.01€
(for every order > 35€)

Collection:
Pages: 108
ISBN : 2-7420-0289-8
Printed in: English

The product of a workshop bringing together leading international specialists, this extremely concise book provides, in just a few pages, a complete overview of the diagnosis and latest forms of treatment for ulcerative colitis, focusing in particular on the effectiveness in situ of treating the ulcerated mucous membrane directly.
The authors deal in turn with the full range of therapeutic resources now available to practitioners (5-ASA, corticosteroids, budesonide, local treatment, etc.) and take care to indicate precisely the best strategy to adopt, along with degree of effectiveness, doses to be prescribed and tolerance levels.
Each chapter ends with a "Discussion" section which highlights the complementary viewpoints of workshop participants talking about their individual clinical experiences. This original approach gives the reader a complete and objective overview of the topic.
At the leading edge of therapeutic practice, this book offers a clear, concrete response to gastroenterologists and pharmacologists involved in the treatment of ulcerative colitis.
This book is written entirely in English.

Contents
• Diagnosis of distal ulcerative colitis (and cryptogenetic proctitis). What are the criteria needed in clinical practice and trials ?
• Efficacy criteria in the treatment of distal ulcerative colitis
• Present dosage forms for ulcerative colitis treatment
• Efficacy and tolerance of topical treatments for active ulcerative colitis: corticosteroids, budesonide
• Efficacy and tolerance of rectal 5-aminosalicylic acid for distal ulcerative colitis
• Local treatments for distal ulcerative colitis and cryptogenetic proctitis. The situation in France.
• Treatment strategies for distal colitis
• Management of refractory proctitis

Authors
Jean-Marc AIACHE, Faculty of Pharmacy, Clermont-Ferrand, France
Antoine CORTOT, Claude-Huriez Hospital, Lille, France
Stephen B. HANAUER, Pritzker School of Medicine, Chicago USA
E. Jan, IRVINE, McMaster University Medical Centre, Hamilton, Ontario, Canada
Marc LÉMANN, Saint-Louis Hospital, Paris, France
John K. MARSHALL, McMaster University Medical Centre, Hamilton, Ontario, Canada
Philippe MARTEAU, Laennec Hospital, Paris V University University, Paris, France
Daniel H. PRESENT, Mount Sinai Medical Center, New York, USA
Gérard SCHÉNOWITZ, Nice, France